Back to top
more

Medpace (MEDP)

(Real Time Quote from BATS)

$388.86 USD

388.86
3,300

+2.52 (0.65%)

Updated Jun 3, 2024 09:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Cigna Poised for Growth in 2019 on Express Scripts Buyout

by Zacks Equity Research

The purchase of Express Scripts by Cigna (CI) has diversified its business, which should fuel long-term growth.

MEDP or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MEDP vs. HQY: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace

5 Healthcare Bets to Stay in Investors Good Books Next Year

by Zacks Equity Research

Based on a few key factors, we zero in on five stocks that show promise to retain the bull run in 2019.

Teladoc (TDOC) Surges 64% in a Year: Can the Rally Continue?

by Zacks Equity Research

Teladoc (TDOC) is poised to grow on accelerating demand for its telehealth services.

PRA Health Sciences (PRAH) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

PRA Health Sciences (PRAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

BioTelemetry (BEAT) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

MEDP vs. PRAH: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

MEDP vs. PRAH: Which Stock Is the Better Value Option?

BioTelemetry (BEAT) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

MEDP vs. PRAH: Which Stock Is the Better Value Option?

by Zacks Equity Research

MEDP vs. PRAH: Which Stock Is the Better Value Option?

Medpace (MEDP) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Medpace (MEDP) delivered earnings and revenue surprises of 6.35% and 2.39%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Medpace Holdings (MEDP) in Q3 Earnings?

by Zacks Equity Research

Medpace Holdings' (MEDP) revenue growth in Q3 to be driven by strength in oncology, cardiometabolic, antiviral and anti-infectious diseases solutions.

Medpace (MEDP) Q3 Earnings Preview: What to Know Ahead of the Release

by Zacks Equity Research

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Community Health's (CYH) Subsidiary to Clear Fraud Charges

by Zacks Equity Research

Community Health Systems' (CYH) arm to settle whistleblower lawsuits alleging a wide-ranging misconduct in emergency rooms.

    Here's Why Medpace (MEDP) is a Great Momentum Stock

    by Zacks Equity Research

    Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.

      Teladoc Leads Telehealth Thanks to its Virtual Care Solution

      by Zacks Equity Research

      Teladoc's (TDOC) vast product portfolio, client base, tie-ups and acquisitions make it a leader in the telehealth industry.

        Has Medpace Holdings (MEDP) Outpaced Other Medical Stocks This Year?

        by Zacks Equity Research

        Is (MEDP) Outperforming Other Medical Stocks This Year?

          Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

          by Zacks Equity Research

          Style Box ETF report for FYC

            Sreyoshi Mukherjee headshot

            Medical Services Boom Drives Healthcare: 3 Top Picks

            by Sreyoshi Mukherjee

            Considering the rising popularity of PBM, CRO and EHR in the U.S. Medical Services industry, these three picks might be money-spinning choices for investors.

              Acadia Healthcare to Benefit from Growing Behavioral Issues

              by Zacks Equity Research

              Acadia Healthcare (ACHC) is well placed to serve patients with increasing incidence of behavioral and mental health illness.

                HCA Healthcare Up 11% Since Q2, Will the Rally Continue?

                by Zacks Equity Research

                HCA Healthcare's (HCA) shares rallied led by strong second-quarter results.

                  Teladoc (TDOC) Up 26% in 22 Days, Will Upside Continue?

                  by Zacks Equity Research

                  Teladoc (TDOC) shares gain on strong operating performance in second quarter.

                    Nalak Das headshot

                    VIX Plunges to 7-Month Low: 5 Top-Ranked Momentum Picks

                    by Nalak Das

                    Since stock market performance and volatility index move in opposite directions, this is an extremely positive sign for the U.S. stocks.

                      Why Teladoc (TDOC) Stock Has More Than Doubled in a Year

                      by Zacks Equity Research

                      Teladoc (TDOC) continues to gain from high demand for its telehealth services.